R‐COMP VS R‐CHOP AS FIRST‐LINE THERAPY FOR DIFFUSE LARGE B‐CELL LYMPHOMA IN PATIENTS OLDER THAN 60 YEARS: RESULTS FROM A RANDOMIZED PHASE 2 STUDY FROM THE SPANISH GELTAMO GROUP. (June 2017) - Sancho, J.; Gual, F.; Fernández‐Álvarez, R.; González‐García, E.; Grande, C.; Gutiérrez, N.; Peñarrubia, M.; Batlle‐López, A.; González‐Barca, E.; Guinea, J.; Gimeno, E.; Peñalver, F.; et al.